The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction
Abstract
Background Elevated plasma neurohormonal levels are associated with increased mortality rates in patients with symptomatic heart failure. A previous Studies of Left Ventricular Dysfunction (SOLVD) trial suggested that neurohumoral activation precedes the development of symptoms as demonstrated by increased neurohormonal levels in patients with asymptomatic left ventricular dysfunction. However, the significance of this early neurohumoral activation is unclear. The goals of this study were to determine the prognostic significance of the plasma concentrations of plasma norepinephrine (PNE) and atrial natriuretic peptide (ANP) and the renin activity (PRA) in patients with asymptomatic left ventricular dysfunction. Methods and Results PNE and PRA were measured before randomization in 514 patients with left ventricular ejection fractions ≤35% who did not require treatment for congestive heart failure and were enrolled in the SOLVD Prevention Trial. Plasma ANP levels were measured in a subset of 241 patients owing to study design. Using the Cox proportional hazards model that included left ventricular ejection fraction, New York Heart Association functional class, age, sex, treatment assignment to placebo or enalapril, and cause of heart failure, we examined whether these neurohormones predicted all-cause mortality, cardiovascular mortality, hospitalization for heart failure, development of heart failure, or development of ischemic events (myocardial infarction or unstable angina). PNE was the strongest predictor of clinical events in this patient population. PNE levels above the median of 393 pg/mL were associated with a relative risk of 2.59 ( P =.002) for all-cause mortality, 2.55 ( P =.003) for cardiovascular mortality, 2.55 ( P =.005) for hospitalization for heart failure, 1.88 ( P =.002) for development of heart failure, 1.92 ( P =.001) for ischemic events, and 2.59 ( P =.005) for myocardial infarction. PNE remained the most powerful predictor for all-cause mortality and ischemic events when the analysis included only the patients with histories of ischemic left ventricular dysfunction. The increases in other neurohormonal levels were not useful in predicting the subsequent development of clinical events. Conclusions Increased PNE levels in patients with asymptomatic left ventricular dysfunction appear to predict all-cause and cardiovascular mortalities and development of clinical events related to the onset of heart failure or acute ischemic syndromes. Thus, measurement of PNE may be a possible early marker for assessment of disease progression in patients with left ventricular dysfunction, and modulating the release or effect of PNE may lead to improved prognosis and/or a reduction in morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Self-citationFrancis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Self-citationBeneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986) · Circulation · doi:10.1161/01.cir.73.5.913 · Cited by 812
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citationLee, W. H., & Packer, M. (1986) · Circulation · doi:10.1161/01.cir.73.2.257 · Cited by 552
Curtiss, C., Cohn, J. N., Vrobel, T., & Franciosa, J. A. (1978) · Circulation · doi:10.1161/01.cir.58.5.763 · Cited by 392
Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
Gottlieb, S. S., Kukin, M. L., Ahern, D., & Packer, M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90344-6 · Cited by 354
Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 318
Rouleau, J.-L., Packer, M., Moyé, L., de Champlain, J., Bichet, D., Klein, M., Rouleau, J. R., Sussex, B., Arnold, J. M., Sestier, F., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90001-9 · Cited by 285
Benedict, C. R., Johnstone, D. E., Weiner, D. H., Bourassa, M. G., Bittner, V., Kay, R., Kirlin, P., Greenberg, B., Kohn, R. M., Nicklas, J. M., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90385-9 · Cited by 225
Self-citationThe SOLVD Investigators (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90842-o · Cited by 187
Atrial pressure and secretion of atrial natriuretic factor into the human central circulation
Rodeheffer, R. J., Tanaka, I., Imada, T., Hollister, A. S., Robertson, D., & Inagami, T. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80086-9 · Cited by 181
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
Benedict, C. R., Francis, G. S., Shelton, B. J., Johnstone, D. E., Kubo, S. H., Kirlin, P. C., Nicklas, J. M., Liang, C., Konstam, M. A., Greenberg, B., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80748-6 · Cited by 110
Self-citationNeurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.
Francis, G. S., McDonald, K., & Cohn, J. N. (1993) · PubMed · Cited by 100
Self-citationSigurðsson, A. F., Amtorp, O., GUNDERSEN, T., Nilsson, B., Remes, J., & Swedberg, K. B. (1994) · Heart · doi:10.1136/hrt.72.5.422 · Cited by 51
Hussain, M. N., & Benedict, C. R. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.11.1861 · Cited by 41
Self-citationNeurohumoral Aspects of Heart Failure
Benedict, C. R. (1994) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30122-x · Cited by 34
Self-citationFleiss, J. L., Bigger, J. T., McDermott, M. W., Miller, J. P., Moon, T., Moss, A. J., Oakes, D., Rolnitzky, L. M., & Therneau, T. (1990) · Circulation · doi:10.1161/01.cir.81.2.684 · Cited by 25
Laragh, J. H. (1980) · Medical Entomology and Zoology · Cited by 22
Mechanisms in heart failure and the role of angiotensin-converting enzyme inhibition
Cohn, J. N. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90470-l · Cited by 14
Neurohumoral variability in left ventricular dysfunction
Kirlin, P. C., Benedict, C. R., Shelton, B. J., Francis, G. S., Nicklas, J. M., Liang, C., Kubo, S. H., Johnstone, D. E., Probstfield, J. L., & Yusuf, S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80553-0 · Cited by 8
Self-citation
Cited by
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 699
Santos-Gallego, C. G., Requena-Ibanez, J. A., San Antonio, R., Ishikawa, K., Watanabe, S., Picatoste, B., Flores, E., Garcia-Ropero, A., Sanz, J., Hajjar, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.056 · Cited by 651
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Calmodulin kinase II inhibition protects against structural heart disease
Zhang, R., Khoo, M. S. C., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., Price, E. E., Thiel, W., Guatimosim, S., Song, L.-S., et al. (2005) · Nature Medicine · doi:10.1038/nm1215 · Cited by 579
Metadata
- Authors
- Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S.
- Venue
- Circulation
- Published
- 1996-08-15
- Volume
- 94
- Issue
- 4
- Pages
- 690-697
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1967340565
- Cited by
- 353
- References
- 26
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.